CTRI/2019/10/021479Not yet recruitingPhase 1
A placebo controlled, randomized double blinded trial to evaluate the use of Tolvaptan for correction of hyponatremia in Liver Cirrhosis patients - SCoTCH
Amrita Institute of Medical Science0 sites0 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 1
- Status
- Not yet recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •1. Patients aged between 18 and 75 years
- •2. Definite history of cirrhosis- signs and symptoms of decompensated cirrhosis, such as splenomegaly, hypersplenism, variceal bleeding, ascites, and hepatic encephalopathy or confirmed cirrhosis by measurements
- •3. Cirrhosis as evidenced by USG or Cross Sectional imaging
- •4. Hyponatremia (Na <125 mEq/L)
Exclusion Criteria
- •1. Patients < 18 years age
- •2. Pregnancy
- •3. Serum Creatinine > 1.5mg/dl
- •4. Nervous system diseases
- •5. Poorly controlled diabetes (fasting glucose > 220 mg/dL)
- •6. Heart failure with ascites
- •7. SIADH (as per Bartter-Schwartz criteria)
- •8. Anuria (urine volume < 100 mL/day)
- •9. Cerebrovascular accident within 30 days prior to the study
Investigators
Similar Trials
Recruiting
Not Applicable
Deep Brain Stimulation for Cerebral PalsyCerebral PalsyACTRN12610000385044Martin Krause40
Completed
Phase 1
Controlled Human Infection for Penicillin Against Streptococcus PyogenesStreptococcus pyogenes pharyngitisStreptococcus pharyngitisStrep throatStreptococcus pyogenes infectionGroup A Streptococcus: B haemolytic pharyngitisGram positive bacterial infectionRecurrent rheumatic feverInfection - Studies of infection and infectious agentsInfection - Other infectious diseasesInflammatory and Immune System - Other inflammatory or immune system disordersRespiratory - Other respiratory disorders / diseasesBlood - Other blood disordersAcute rheumatic feverGroup A streptococcal infectionBacterial infectionACTRN12621000751875Telethon Kids Institute60
Completed
Phase 2
actoferrin Supplementation, Immune Function & Respiratory Virus Infection in healthy, older adults: The LIFE TrialImmune functionRespiratory virus infectionInflammationInflammatory and Immune System - Normal development and function of the immune systemInfection - Studies of infection and infectious agentsACTRN12621001511820The University of Newcastle103
Completed
Phase 2
Effects of perioperative Recombinant Human Erythropoietin administration on proinflammatory cascade following breast cancer surgery.Female subjects with breast cancer stage II/III undergoing a modified radical mastectomyCancer - BreastInflammatory and Immune System - Other inflammatory or immune system disordersACTRN12610000813088niversity Hospital of Ioannina22
Completed
Not Applicable
Efficacy evaluation of hair tonic in healthy human subjectsCTRI/2018/03/012284ITC R D Centre82
